Axsome Therapeutics is a biopharmaceutical company that is revolutionizing the treatment of central nervous system (CNS) conditions. With a focus on developing innovative therapeutic options, we are transforming the approach to treating conditions like depression, migraine, Alzheimer's disease, agitation, and more. Our goal is to improve the lives of patients and provide additional therapeutic choices for physicians.

Through our science-driven approach, we are developing novel therapies with unique mechanisms of action. We are committed to creating products that make a meaningful difference in patients' lives. At Axsome, we pride ourselves on our extensive pipeline of potential treatments.

Our dedicated team of experts is working tirelessly to bring these innovative therapies to market. To learn more about our pipeline and meet our management team, visit our website. Axsome Therapeutics is at the forefront of transforming CNS treatment and bringing hope to those with limited treatment options